| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 10/20/2005 | CA2546150A1 Estrogen receptor modulators |
| 10/19/2005 | EP1586579A1 Process for the preparation of delta(15-16)-17-ketosteroids and use thereof in the synthesis of pharmacologically active compounds |
| 10/19/2005 | EP1586323A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/18/2005 | US6956126 Binding to estrogen receptors |
| 10/18/2005 | CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol |
| 10/12/2005 | EP1272195B1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/06/2005 | US20050222114 Use of new etonogestrel esters |
| 10/06/2005 | US20050222113 New etonogestrel esters |
| 09/29/2005 | WO2005089256A2 Antiangiogenic agents |
| 09/29/2005 | CA2558014A1 Antiangiogenic agents |
| 09/28/2005 | EP1580192A2 16-Hydroxyestratrienes as selective estrogens |
| 09/28/2005 | EP0552202B2 Methods mediated by the proto-oncogenic protein complex AP-1 |
| 09/28/2005 | CN1220696C 16 alpha-methyl or ethyl substituted estrogens |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 09/22/2005 | WO2005087225A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 09/22/2005 | CA2601038A1 Methods and compositions for treating cancer |
| 09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/15/2005 | US20050203075 Antiangiogenic agents |
| 09/14/2005 | CN1666993A Steroid compounds preparation method |
| 09/07/2005 | EP1569648A1 Prodrugs for use a ophthalmic agents |
| 09/07/2005 | CN1665516A Infertility treatment with exemestane |
| 09/01/2005 | US20050192258 Treating disease states characterized by abnormal cell mitosis and abnormal angiogenesis with analogs of 2-methoxyestradiol modified at the 2, 16 or 17 positions; reduced metabolism at position-17 and -2. 17; nontoxic; antitumor, -carcinogenic, prolierative agents; antitarthritic agents; vision defecfs |
| 08/31/2005 | EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen |
| 08/31/2005 | CN1660884A Anthraquinone ramification of rhubarb, preparing method and combination of medication by using the ramification as active ingredient |
| 08/25/2005 | WO2005047303A3 NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/24/2005 | EP1504019B1 Platinum complexes having antitumor activity |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens |
| 08/17/2005 | EP1562976A2 Synthesis of estetrol via estrone derived steroids |
| 08/17/2005 | EP1562974A1 Processes for preparing c-7 substituted 5-androstenes |
| 08/17/2005 | CN1655848A Use of new etonogestrel esters |
| 08/16/2005 | US6930192 Methods for preparing 7alpha-hydroxy-dehydroepiandrosterone |
| 08/16/2005 | US6930128 Estrogenic compounds as anti-mitotic agents |
| 08/11/2005 | US20050176952 Phenanthrene compounds |
| 08/10/2005 | EP1560841A1 Processes for preparing 7-carboxy substituted steroids |
| 08/10/2005 | CN1653082A Platinum complexes having antitumor activity |
| 08/10/2005 | CN1653081A C-17 spirolactonization and 6, 7 oxidation of steroids |
| 08/10/2005 | CN1213755C Use of exemestane in preparing medicinal composition for first-line treatment of breast cancer |
| 08/04/2005 | WO2005070951A1 Exemestane and its intermediates and methods of making the same |
| 08/04/2005 | WO2005070950A1 Di-steroidal prodrugs of ethinyl estradiol |
| 08/04/2005 | WO2005070949A1 Di-steroidal prodrugs of estradiol |
| 08/04/2005 | WO2005048956A3 Estradiol-related compounds and methods of use as anti-tumor agents |
| 08/04/2005 | CA2553816A1 Di-steroidal prodrugs of ethinyl estradiol |
| 08/04/2005 | CA2553815A1 Di-steroidal prodrugs of estradiol |
| 07/28/2005 | US20050164998 Of pregnant mares; filtering solids, basic buffering, reducing phenolic content, separating esterified steroids using a series of nonionic and ionic exchange resins; improved industrial scale batch uniformity of conjugated estrogens over Premarin"; hormone replacement therapy |
| 07/28/2005 | US20050164991 7-Oxo-DHEA compounds for treating keratinous conditions/afflictions |
| 07/27/2005 | CN1646555A Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 07/21/2005 | WO2005066194A1 Helix 12 directed steroidal pharmaceutical products |
| 07/21/2005 | WO2005066114A1 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders |
| 07/21/2005 | WO2004041839A8 Synthesis of estetrol via estrone derived steroids |
| 07/21/2005 | US20050159609 Reacting ethinyl estradiol with a linking goup slected from a carbonate, a polyoxyethylene glycol and succinic anhydride, an aliphatic diacid, a peptide linkage having 2-15 amia tert-butoxycarbonyl protected cysteic acidno acids |
| 07/21/2005 | US20050159594 Aldosterone receptor antagonist; comprises 7-methyl hydrogen 4a,5a;9a,11a-diepoxy-17 hydroxy-3-oxo-17a-pregnane-7a,21-dicarboxylate, gamma-lactone as dopant |
| 07/21/2005 | US20050159399 Reacting an estradiol with a linking goup slected from a carbonate, a polyoxyethylene glycol and succinic anhydride, an aliphatic diacid, a peptide linkage having 2-15 amia tert-butoxycarbonyl protected cysteic acidno acids |
| 07/21/2005 | US20050159366 a 6-bromo-3-hydroxyandrostan-17-one compound; viricides; immunosuppressants |
| 07/21/2005 | US20050158727 Derivatized oligonucleotides having improved uptake and other properties |
| 07/20/2005 | EP1555327A1 Method and reagent for measuring cholesterol in high-density lipoproteins |
| 07/20/2005 | EP1555025A2 Use of dehydroepiandrosterone analogs for the treatment of asthma |
| 07/20/2005 | CN1211396C Female hormore compound of bone tendency, preparing method and application thereof |
| 07/20/2005 | CN1211395C Female hormore compound of bone tendency, preparing method and application thereof |
| 07/19/2005 | US6919439 Derivatized oligonucleotides having improved uptake and other properties |
| 07/14/2005 | US20050153949 Testosterone derivative |
| 07/13/2005 | EP1551416A2 Method for treating erectile dysfunction and increasing libido in men |
| 07/13/2005 | CN1637016A Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 07/13/2005 | CN1637015A 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/13/2005 | CN1636555A Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 07/12/2005 | CA2298142C Soya extract, process for its preparation and pharmaceutical composition |
| 07/12/2005 | CA2231781C Novel steroid esters useful against skin disorders |
| 07/07/2005 | US20050148561 Novel triterpene derivatives, preparation thereof and use thereof |
| 07/06/2005 | CN1634967A Sterol refining process |
| 06/30/2005 | US20050143366 Compounds for diagnosis, treatment and prevention of bone injury and metabolic disorders |
| 06/30/2005 | DE102004046154A1 Verfahren zur Massenspektrometrie A method of mass spectrometry |
| 06/29/2005 | CN1633445A Process to prepare eplerenone |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1632116A Enhancement of virus-mediated DNA transfer |
| 06/21/2005 | US6908910 Antiproliferative agent; wound healing agents; antiinflammatory agents |
| 06/21/2005 | CA2213339C Method of treating adenosine depletion |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/16/2005 | US20050130944 Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate |
| 06/15/2005 | EP1539795A1 Crystalline 17beta-hydroxy-7alpha-(5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone |
| 06/15/2005 | EP1251856B1 Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices |
| 06/15/2005 | CN1627952A Separation of cresol from mare's urine |
| 06/15/2005 | CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 06/14/2005 | US6906049 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
| 06/09/2005 | WO2005051972A1 Estrogen receptor modulators |
| 06/09/2005 | CA2546116A1 Estrogen receptor modulators |
| 06/08/2005 | EP1172371B1 Process for the preparation of steroid derivatives |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | CN1204859C Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 06/02/2005 | WO2005048956A2 Estradiol-related compounds and methods of use as anti-tumor agents |
| 06/02/2005 | US20050118312 product as useful in ameliorating symptoms associated with menopause comprising pomegranate seed oil product and pomegranate fruit or juice product |
| 06/02/2005 | US20050118242 Using testosterone; topical applying to skins |
| 06/01/2005 | EP1534732A2 5 ANDROSTEN-3&bgr;-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION |
| 05/31/2005 | US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent |
| 05/26/2005 | WO2005047303A2 NOVEL 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS |
| 05/26/2005 | WO2005000245A3 Compositions and methods for increasing telomerase activity |
| 05/25/2005 | EP1531829A2 Infertility treatment with exemestane |
| 05/19/2005 | WO2005032560A3 Biological action of optically active isomers of digoxin |
| 05/19/2005 | US20050107337 Platinum complexes having antitumor activity |
| 05/18/2005 | EP1530478A2 Exemestane for first-line treatment of breast cancer |